[Improved antilipemic drug is approved. Cholesterol absorption is inhibited].
D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001384:Azetidines / Q000009:adverse effects / Q000627:therapeutic use*; D002791:Cholesterol, Dietary / Q000378:metabolism*; D008078:Cholesterol, LDL / Q000097:blood*; D017277:Drug Approval; D005060:Europe; D000069438:Ezetimibe; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects*
D000924:Anticholesteremic Agents; D001384:Azetidines; D002791:Cholesterol, Dietary; D008078:Cholesterol, LDL; D000069438:Ezetimibe